Christos Markellos
Athens, ESYE31 11528, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Optimal Time Interval between Neoadjuvant Platinum-Based Chemotherapy and Interval Debulking Surgery in High-Grade Serous Ovarian Cancer.
Journal: Cancers
Published: May 28, 2023
Subarachnoid hemorrhage in a postpartum mother: A rare manifestation of an uncommon disease.
Journal: Gynecologic oncology reports
Published: September 07, 2022
Assessment of Postvaccination Neutralizing Antibodies Response against SARS-CoV-2 in Cancer Patients under Treatment with Targeted Agents.
Journal: Vaccines
Published: July 11, 2022
Oncological Patients With Endocrine Complications After Immunotherapy With Checkpoint Inhibitors Present Longer Progression-Free and Overall Survival.
Journal: Frontiers in oncology
Published: January 03, 2022
Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy.
Journal: Journal of ovarian research
Published: June 30, 2021
SARS-CoV-2 neutralizing antibodies after first vaccination dose in breast cancer patients receiving CDK4/6 inhibitors.
Journal: Breast (Edinburgh, Scotland)
Published: June 03, 2021
Treatment with abiraterone or enzalutamide does not impair immunological response to COVID-19 vaccination in prostate cancer patients.
Journal: Prostate cancer and prostatic diseases
Published: May 27, 2021
Low titers of SARS-CoV-2 neutralizing antibodies after first vaccination dose in cancer patients receiving checkpoint inhibitors.
Journal: Journal of hematology & oncology
Published: April 28, 2021
CDK4/6 Inhibitors and Arthralgia: A Single Institution Experience.
Journal: Medical sciences (Basel, Switzerland)
Published: March 23, 2021
Last Updated: 09/26/2026